These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 17437058)
41. Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells. Yang AQ; Wang PJ; Huang T; Zhou WL; Landman J Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173182 [TBL] [Abstract][Full Text] [Related]
42. The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells. Wagener N; Holland D; Bulkescher J; Crnković-Mertens I; Hoppe-Seyler K; Zentgraf H; Pritsch M; Buse S; Pfitzenmaier J; Haferkamp A; Hohenfellner M; Hoppe-Seyler F Int J Cancer; 2008 Oct; 123(7):1545-50. PubMed ID: 18623083 [TBL] [Abstract][Full Text] [Related]
43. The effects on cell growth and chemosensitivity by livin RNAi in non-small cell lung cancer. Yuan D; Liu L; Xu H; Gu D Mol Cell Biochem; 2009 Jan; 320(1-2):133-40. PubMed ID: 18827979 [TBL] [Abstract][Full Text] [Related]
44. Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB. Chen F; Yang D; Che X; Wang J; Li X; Zhang Z; Chen X; Song X Oncol Rep; 2012 Jun; 27(6):2010-6. PubMed ID: 22427141 [TBL] [Abstract][Full Text] [Related]
45. Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells. Wang H; Tan SS; Wang XY; Liu DH; Yu CS; Bai ZL; He DL; Zhao J Acta Pharmacol Sin; 2007 Dec; 28(12):1968-74. PubMed ID: 18031611 [TBL] [Abstract][Full Text] [Related]
46. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298 [TBL] [Abstract][Full Text] [Related]
47. RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells. Li X; Fan S; Li L; Wang L; Fan G; Zhao Q; Li Y Int J Oncol; 2013 Jul; 43(1):159-68. PubMed ID: 23632777 [TBL] [Abstract][Full Text] [Related]
48. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment. Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709 [TBL] [Abstract][Full Text] [Related]
49. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome. Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668 [TBL] [Abstract][Full Text] [Related]
50. Role of inhibitor of apoptosis protein Livin in radiation resistance in nonsmall cell lung cancer. Sun JG; Liao RX; Zhang SX; Duan YZ; Zhuo WL; Wang XX; Wang ZX; Li DZ; Chen ZT Cancer Biother Radiopharm; 2011 Oct; 26(5):585-92. PubMed ID: 21883015 [TBL] [Abstract][Full Text] [Related]
51. Silencing of Livin inhibits tumorigenesis and metastasis via VEGF and MMPs pathway in lung cancer. Lin X; Li HR; Lin XF; Yu ME; Tu XW; Hua ZD; Lin M; Xu NL; Han LL; Chen YS Int J Oncol; 2015 Aug; 47(2):657-67. PubMed ID: 26094984 [TBL] [Abstract][Full Text] [Related]
52. Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin. Abd-Elrahman I; Deutsch V; Pick M; Kay S; Neuman T; Perlman R; Ben-Yehuda D Cell Death Dis; 2013 Nov; 4(11):e937. PubMed ID: 24287698 [TBL] [Abstract][Full Text] [Related]
53. [Effects of human Livin gene down-regulation by RNA interference on xenograft of transplantation tumor induced by SPC-A1 in nude mice]. Chen YS; Li YT; Li HR; Chen XY; Lin LF Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jan; 34(1):43-7. PubMed ID: 21429419 [TBL] [Abstract][Full Text] [Related]
54. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer. Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165 [TBL] [Abstract][Full Text] [Related]
55. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors. Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838 [TBL] [Abstract][Full Text] [Related]
56. Expression and functional role of inhibitor-of-apoptosis protein livin (BIRC7) in neuroblastoma. Dasgupta A; Alvarado CS; Xu Z; Findley HW Biochem Biophys Res Commun; 2010 Sep; 400(1):53-9. PubMed ID: 20691667 [TBL] [Abstract][Full Text] [Related]
57. [Apoptosis induction effect of siRNA recombinant expression vector targeting Livin and Survivin gene simultaneously on human colon cancer cells]. Cai M; Wang GB; Tao KX; Cai CX Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):399-403. PubMed ID: 19598029 [TBL] [Abstract][Full Text] [Related]
58. Challenge and promise: roles for Livin in progression and therapy of cancer. Wang L; Zhang Q; Liu B; Han M; Shan B Mol Cancer Ther; 2008 Dec; 7(12):3661-9. PubMed ID: 19074843 [TBL] [Abstract][Full Text] [Related]
59. Expression of Livin in colorectal cancer and its relationship to tumor cell behavior and prognosis. Myung DS; Park YL; Chung CY; Park HC; Kim JS; Cho SB; Lee WS; Lee KH; Lee JH; Joo YE PLoS One; 2013; 8(9):e73262. PubMed ID: 24023847 [TBL] [Abstract][Full Text] [Related]
60. Local injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrest. Chen YS; Li HR; Miao Y; Chen WY; Li YT; Wang GQ; Wu ZC Int J Clin Exp Pathol; 2012; 5(8):796-805. PubMed ID: 23071862 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]